Literature DB >> 21458151

Feasibility of transvaginal natural orifice transluminal endoscopic surgery-assisted living donor nephrectomy: is kidney vaginal delivery the approach of the future?

Antonio Alcaraz1, Mireia Musquera, Lluis Peri, Laura Izquierdo, Eduard García-Cruz, Jorge Huguet, Ricardo Alvarez-Vijande, Josep M Campistol, Federico Oppenheimer, Maria J Ribal.   

Abstract

BACKGROUND: Natural orifice transluminal endoscopic surgery (NOTES) uses natural orifices to access the abdominal cavity. We adapted NOTES to perform transvaginal NOTES-assisted laparoscopic nephrectomy in living donors.
OBJECTIVE: To assess the feasibility and reproducibility of this procedure and compare it with conventional laparoscopic living donor nephrectomy (LLDN). DESIGN, SETTING, AND PARTICIPANTS: From July 2009 to October 2010, 20 women underwent transvaginal NOTES-assisted living donor nephrectomy (LDN) in our centre. We compared the prospectively collected clinical data of each donor with those of a contemporaneous matched pair of conventional LLDNs (40 donors). SURGICAL PROCEDURE: The procedure was performed using three abdominal trocars and one trocar through the vaginal wall. MEASUREMENTS: Variables evaluated for donors were procedure length, blood loss, warm ischaemia time (WIT), complications, hospital stay, and first-month creatinine nadir. In the transvaginal LDN group, sexual function was assessed with the Female Sexual Function Index questionnaire before and after surgery. Variables evaluated for recipients were complications, graft function, and creatinine evolution. RESULTS AND LIMITATIONS: The procedure was completed in all cases. Operative variables were similar for both groups except for WIT, which was longer in the transvaginal LDN group (p<0.001) without consequences for graft functioning. One transvaginal LDN case had postoperative bleeding requiring immediate open surgery. All transvaginal LDN donors reported unaltered sexual function after surgery and satisfaction with the results. All recipients had immediate urine output, and all had a functioning graft at last follow-up except for one recipient of the transvaginal LDN group who required transplantectomy. Despite promising results, randomised controlled studies with longer follow-up are warranted to further elucidate the potential of this novel technique.
CONCLUSIONS: Transvaginal NOTES-assisted LDN appears to be a feasible and reproducible surgical technique. The WIT was longer in the transvaginal group, and there was no effect on graft function after the short follow-up.
Copyright © 2011 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21458151     DOI: 10.1016/j.eururo.2011.03.021

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  21 in total

Review 1.  Laparoendoscopic single-site surgery in kidney surgery: clinical experience and future perspectives.

Authors:  Panagiotis Kallidonis; Stavros Kontogiannis; Iason Kyriazis; Ioannis Georgiopoulos; Abdulrahman Al-Aown; Jens-Uwe Stolzenburg; Evangelos Liatsikos
Journal:  Curr Urol Rep       Date:  2013-10       Impact factor: 3.092

2.  Robotic renal transplant recipient surgery with vaginally inserted allograft.

Authors:  Vishnu Raveendran; Kishore Thekke Adiyat; Ramaprasad Manasseri Koduveli; Roy John
Journal:  J Robot Surg       Date:  2017-03-20

Review 3.  Evolution and simplified terminology of natural orifice transluminal endoscopic surgery (NOTES), laparoendoscopic single-site surgery (LESS), and mini-laparoscopy (ML).

Authors:  A N Georgiou; J Rassweiler; T R Herrmann; J U Stolzenburg; E N Liatsikos; Eta Mu Do; P Kallidonis; A de la Teille; R van Velthoven; M Burchardt
Journal:  World J Urol       Date:  2012-07-13       Impact factor: 4.226

Review 4.  Urological applications of natural orifice transluminal endoscopic surgery (NOTES).

Authors:  Mark D Tyson; Mitchell R Humphreys
Journal:  Nat Rev Urol       Date:  2014-05-13       Impact factor: 14.432

5.  Systematic Review and Meta-analysis of Complications in Transvaginal Approach in Laparoscopic Surgery.

Authors:  Andrzej L Komorowski; Francisco Alba Mesa; Małgorzata M Bała; Jerzy W Mituś; Wojciech M Wysocki
Journal:  Indian J Surg       Date:  2014-02-05       Impact factor: 0.656

6.  Mini-laparoscopic live donor nephrectomy with the use of 3-mm instruments and laparoscope.

Authors:  Alberto Breda; Ivan Schwartzmann; Esteban Emiliani; Oscar Rodriguez-Faba; Lluis Gausa; Jorge Caffaratti; Xavier Ponce de León; Humberto Villavicencio
Journal:  World J Urol       Date:  2014-09-03       Impact factor: 4.226

7.  Perioperative outcome and female sexual function after laparoscopic transvaginal NOTES-assisted nephrectomy.

Authors:  Lluis Peri; Mireia Musquera; Antoni Vilaseca; Eduard Garcia-Cruz; Maria J Ribal; Albert Carrión; Roberto Castañeda; Antonio Alcaraz
Journal:  World J Urol       Date:  2015-05-06       Impact factor: 4.226

8.  First Canadian experience with robotic laparoendoscopic single-site vs. standard laparoscopic living-donor nephrectomy: A prospective comparative study.

Authors:  Patrick P Luke; Shahid Aquil; Bijad Alharbi; Hemant Sharma; Alp Sener
Journal:  Can Urol Assoc J       Date:  2018-06-08       Impact factor: 1.862

9.  KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors.

Authors:  Krista L Lentine; Bertram L Kasiske; Andrew S Levey; Patricia L Adams; Josefina Alberú; Mohamed A Bakr; Lorenzo Gallon; Catherine A Garvey; Sandeep Guleria; Philip Kam-Tao Li; Dorry L Segev; Sandra J Taler; Kazunari Tanabe; Linda Wright; Martin G Zeier; Michael Cheung; Amit X Garg
Journal:  Transplantation       Date:  2017-08       Impact factor: 4.939

10.  Laparoscopic left hemihepatectomy combined with right lateral hepatic lobectomy in pigs: surgical approach and comparative study of the inflammatory response versus open surgery.

Authors:  Hua Zhang; Jin-Jin Tong; Zhao-Nan Zhang; Hong-Bin Wang; Yong-Hong Zhang
Journal:  Vet Res Forum       Date:  2021-03-15       Impact factor: 1.054

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.